Cargando…

Consumption and market share of cholesterol-lowering drugs in high-risk patients before and after the release of the 2013 ACC/AHA cholesterol guidelines: a retrospective observational study

OBJECTIVE: We examined the use of cholesterol-lowering drugs in Taiwan in high-risk patients before and after the release of the 2013 American College of Cardiology and the American Heart Association (ACC/AHA) cholesterol guidelines. DESIGN: Retrospective observational study. SETTING: Kaohsiung Chan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Tzu-Tsen, Huang, Yaw-Bin, Hsieh, Ching-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682459/ https://www.ncbi.nlm.nih.gov/pubmed/33444173 http://dx.doi.org/10.1136/bmjopen-2020-036769

Ejemplares similares

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Subclinical Coronary Atherosclerosis: Implication of Coronary Computed Tomography Angiography Findings among Statin Candidates according to the 2013 ACC/AHA Cholesterol Management Guidelines
por: Seo, Jiwoon, et al.
Publicado: (2019)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
Publicado: (2016)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
por: Egan, Brent M., et al.
Publicado: (2016)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
por: Okerson, Ted, et al.
Publicado: (2017)

The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for cholesterol management and for cardiovascular risk stratification: A reappraisal
por: Bansal, Manish, et al.
Publicado: (2014)

Sex Differences in Statin Prescribing in Diabetic and Heart Disease Patients in FQHCs: A Comparison of the ATPIII and 2013 ACC/AHA Cholesterol Guidelines
por: Khan, Nazia Naz S., et al.
Publicado: (2019)

Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines
por: Matyori, Amro, et al.
Publicado: (2023)

2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population
por: Cho, Yun Kyung, et al.
Publicado: (2016)

Examination of physicians’ adherence to the 2013 ACC/AHA statin/cholesterol guidelines using a framework of awareness to adherence: A cross-sectional study
por: Fleming, Marc L, et al.
Publicado: (2020)

Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management
por: AlAhmad, Mohammad M., et al.
Publicado: (2023)

Trends in Statin Use 2009–2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol
por: Harrison, Teresa N., et al.
Publicado: (2018)

Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol
por: Bellows, Brandon K., et al.
Publicado: (2016)

Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)

Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines
por: von Knobelsdorff-Brenkenhoff, Florian, et al.
Publicado: (2017)

Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan
por: Olufade, Temitope, et al.
Publicado: (2017)

Statin Utilization Among Human-Immunodeficiency Virus (HIV)-Infected Individuals Based on the 2013 American College of Cardiology and American Heart Association (ACC/AHA) Blood Cholesterol Guideline
por: Non, Lemuel, et al.
Publicado: (2017)

Stage 1 hypertension defined by the 2017 ACC/AHA guideline predicts future cardiovascular events in elderly Chinese individuals
por: Xie, Yanxia, et al.
Publicado: (2019)

Similarities in Hypertension Status but Differences in Mortality Risk: A Comparison of 2017 ACC/AHA and 2018 Chinese Hypertension Guidelines
por: Chen, Kangyu, et al.
Publicado: (2022)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore
por: Setia, Sajita, et al.
Publicado: (2015)

The Association of Stage 1 Hypertension, Defined by the 2017 ACC/AHA Guidelines, With Cardiovascular Events Among Rural Women in Liaoning Province, China
por: Wu, Jiake, et al.
Publicado: (2021)

Implication of thoracic aortic calcification over coronary calcium score regarding the 2018 ACC/AHA Multisociety cholesterol guideline: results from the CAC Consortium
por: Han, Donghee, et al.
Publicado: (2021)

Thoracic Aortic Calcification and Pre-Clinical Hypertension by New 2017 ACC/AHA Hypertension Guidelines
por: Jan, Ya-Ting, et al.
Publicado: (2021)

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
por: Levintow, Sara N, et al.
Publicado: (2020)

Incident cerebral microbleeds and hypertension defined by the 2017 ACC/AHA Guidelines
por: Xia, Yiwei, et al.
Publicado: (2021)

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline
por: Cardoso, Rhanderson, et al.
Publicado: (2022)

Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline
por: Alanaeme, Chibuike J., et al.
Publicado: (2022)

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
por: Dong, Yan, et al.
Publicado: (2021)

Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study
por: Hamoui, Omar, et al.
Publicado: (2019)

Hypertension prevalence alteration in 92 815 nurses based on the new standard by 2017 ACC/AHA hypertension guideline: observational cross-sectional study from China
por: Zhao, Bin, et al.
Publicado: (2019)

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022)

Comparison of application of 2013 ACC/AHA guideline and 2011 European Society of Cardiology guideline for the management of dyslipidemias for primary prevention in a Turkish cohort
por: Yılmaz, Mustafa, et al.
Publicado: (2017)

Statin Eligibility according to 2013 ACC/AHA and USPSTF Guidelines among Jordanian Patients with Acute Myocardial Infarction: The Impact of Gender
por: Ibdah, Rashid, et al.
Publicado: (2023)

Change in blood pressure status defined by 2017 ACC/AHA hypertension guideline and risk of cardiovascular disease: results of over a decade of follow-up of the Iranian population
por: Kabootari, Maryam, et al.
Publicado: (2023)

Assessment of the Efficacy of Lowering LDL Cholesterol with Rosuvastatin 10 mg in Four Korean Statin Benefit Groups as per ACC/AHA Guidelines (NewStaR4G)
por: Kim, Kyung-Jin, et al.
Publicado: (2020)

Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline
por: Kibria, Gulam Muhammed Al, et al.
Publicado: (2018)

Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
por: Wenger, Nanette K.
Publicado: (2019)

Prevalence of high blood pressure in Iranian adults based on the 2017 ACC/AHA guideline
por: Hosseini, Mostafa, et al.
Publicado: (2019)

What is new in ACC/AHA 2017 focused update of valvular heart disease guidelines
por: Özkan, Mehmet
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qadhf96hpdbgcdk5dok6qbf1ec